It has now been two months since our conference at Solstrand, and since then I have gathered all your input from the group work on K2s strategy plan.
All your suggestions amounted to four pages of suggestions on what we should keep from our current plan, and what new goals and measures should be included in our new plan. Among other things, your suggestions were a separate goal on innovation at K2 as well as environmental goals and a green strategy. According to your input, we are still in want of meeting places across internal groupings, and career planning for our younger researchers. I am very grateful for your group work at Solstrand and your good input to the new strategy plan.
The new plan will act for three years from 2020 and part of the leader group at K2 will be involved in editing the existing plan. A draft for the new strategy plan will be distributed to all you after the summer. I hope you will take the time both to read and comment when I send it to you.
Kandidater til valget i gruppe B hos K2:
||Saghaug, Christina Skår
Valget er elektronisk og starter tirsdag 28. mai kl 9 og avsluttes kl 12 tirsdag 4. juni.
Mer info her.
To all members of the Norwegian Association of Researchers (Forskerforbundet): NAR hereby announces the 2019 Brain Power Award. Send us your story about the importance of R&D work! Deadline for submission is Monday September 2, 2019.
The purpose of the award is to highlight the role of research and development (R&D) in our community, and to highlight the important job our members do in many areas. The contribution should be a story about why R&D work is important and what importance it has for society. The Brain Power Award aims at establishing a greater understanding that investment in R&D and knowledge are important investments for the future, and to highlight the importance of R&D for the future welfare, industrial and social development; locally, regionally, globally and nationally.
All members of NAR can submit entries for the award, regardless of their job position or place of work.
Contributions can be formulated in various genres and media, whether in the form of an article, an essay, a film, an exhibition or other ways to present the message of the importance of R&D activity. The entry should communicate well to the general public.
The award money is a total of NOK 200 000. A jury appointed by the Executive Board will select the best entries and allocate the award to one or more winners.
The jury will give the award to the contribution(s) that are found to be of the highest quality and with the best ability to disseminate research.
The winner(s) will be announced at our annual Research Policy Conference on November 12, 2019. The winner(s) will also be presented on our website.
More info, and guidelines for contributions here.
Scott Lieberman, MD, PhD
Division of Rheumatology, Carver College of Medicine,
University of Iowa, IA, USA
Title: “Sjögren’s syndrome in children and mice”
Peter Gergely, MD, PhD
Novartis Institutes for Biomedical Research,
Title: “Anti-CD40 therapy in immune-mediated diseases”
Time: Thursday, June 6th, at 14:15 – ca.16:00
Place: Birkhaugsalen, HUS
Tuesday May 28th, Laboratorybuilding room 9.1/9.2
11:00 Marta Erdal
13:00 Erlend Eriksen
14:00 Benedicte Sjo Tislevoll
Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 7 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Hege F. Berg.
Please see below the updated links for external funding:
External funding opportunities: http://www.uib.no/en/med/112772/external-funding-opportunities
Funding opportunities for education: http://www.uib.no/med/113987/funding-opportunities-education
The webpages are updated every second week. New calls are marked as NEW.
Amra, Ramune and Kaia